NFE2L2 and cancer: This finding is of great importance as loss of the KEAP1-dependent regulation of NRF2 is prevalent in several cancers that are hallmarked by resistance to chemo- and radiation- therapies, a side effect of NRF2-dependent activation of cytoprotection pathways.